Results
|
|
1.
|
|
|
|
2.
|
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. MedStar authors:
Year: 2017
Citation: - The Lancet Diabetes & Endocrinology. 5(5):355-366, 2017 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Axelsen M, Bain SC, Cariou B, DeVries JH, Piletic M, Rose L, Rowe E
|
|
|
3.
|
Safety of eptifibatide when added to bivalirudin during ST-segment elevation myocardial infarction. MedStar authors:
- Baker, Nevin C
- Escarcega, Ricardo O
- Lipinski, Michael J
- Magalhaes, Marco A
- Torguson, Rebecca
- Waksman, Ron
Year: 2014
Citation: - Cardiovascular Revascularization Medicine. 15(5):278-83, 2014 Jul-Aug.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Baker NC, Escarcega RO, Lipinski MJ, Magalhaes MA, Torguson R, Waksman R
|
|
|
4.
|
|
|
|
5.
|
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial. MedStar authors:
Year: 2017
Citation: - Obstetrics & Gynecology. 129(1):121-129, 2017 Jan
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Aragaki AK, Cauley JA, Howard BV, Jiang X, Johnson KC, LeBlanc ES, Manson JE, Martin LW, Nudy M, O'Sullivan DM, Payne ME, Robbins J, Schnatz PF, Shikany JM, Stefanick ML, Williams M
|
|
|
6.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(9):1579-86, 2016 Sep
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
|
|
|
7.
|
Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure. MedStar authors:
- Lam, Phillip H
- Mohammed, Selma F
Year: 2020
Citation: - American Journal of Therapeutics. 27(3):e235-e242, 2020 May/Jun.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmed A, Allman RM, Arundel C, Faselis C, Fonarow GC, Jones LG, Jurgens CY, Lam PH, Mohammed SF, Morgan CJ, Sheriff HM
|
|
|
8.
|
|
|
|
9.
|
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects. MedStar authors:
- Hussaini, Azra
- Kostov, Ivan
Year: 2016
Citation: - Antimicrobial Agents & Chemotherapy. 60(12):7321-7332, 2016 Dec
Department: - PAREXEL Early Phase Clinical Unit
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Bouhired S, Duparc S, Goyal N, Green JA, Hussaini A, Jones SW, Koh GC, Kostov I, Mohamed K, Taylor M, Wolstenholm A
|
|
|
10.
|
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(12):2262-2271, 2019 12.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
|
|
|
11.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
|
|
|
12.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
|
13.
|
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
Year: 2014
Citation: - Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
|
|
|
14.
|
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. MedStar authors:
Year: 2015
Citation: - Journal of the American College of Cardiology. 66(20):2201-10, 2015 Nov 17.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Adelman SJ, Brewer HB, Kane JP, Krueger KA, Nicholls SJ, Nissen SE, Rader DJ, Ruotolo G, Wang MD
|
|
|
15.
|
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
Year: 2016
Citation: - Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
|
|
|
16.
|
Safety and efficacy of prasugrel use in patients undergoing percutaneous coronary intervention and anticoagulated with bivalirudin. MedStar authors:
- Kent, Kenneth M
- Laynez-Carnicero, Ana
- Lindsay, Joseph
- Pichard, Augusto D
- Sardi, Gabriel L
- Satler, Lowell F
- Suddath, William O
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Citation: - American Journal of Cardiology. 111(4):516-20, 2013 Feb 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Kent KM, Laynez A, Lindsay J, Pichard AD, Sardi G, Satler LF, Suddath WO, Torguson R, Waksman R, Xue Z
|
|
|
17.
|
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
|
|
|
18.
|
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. MedStar authors:
Citation: - JAMA. 310(13):1353-68, 2013 Oct 2.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Intramural
All authors: - Anderson G, Aragaki AK, Beresford SA, Cauley JA, Chlebowski RT, Eaton CB, Gass M, Howard BV, Hsia J, Jackson RD, Johnson KC, Kooperberg C, Kuller LH, LaCroix AZ, Lewis CE, Limacher M, Liu S, Manson JE, Margolis KL, Martin LW, O'Sullivan MJ, Ockene JK, Powell LH, Prentice RL, Rossouw JE, Simon MS, Stefanick ML, Thomson CA, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Wassertheil-Smoller S
|
|
|
19.
|
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. MedStar authors:
Citation: - New England Journal of Medicine. 373(8):714-25, 2015 Aug 20.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ackerman P, ALLY-2 Investigators, Dieterich D, Dretler R, Fishbein D, Gathe JC Jr, Henn S, Hinestrosa F, Hughes E, Huynh C, Liu Z, Luetkemeyer A, McDonald C, McPhee F, Mills A, Morgan TR, Noviello S, Overton ET, Ramgopal M, Rashbaum B, Ray G, Ruane PJ, Scarsella A, Sherman KE, Sulkowski MS, Wyles DL, Yin PD, Yozviak J
|
|
|
20.
|
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). MedStar authors:
- Kaneshige, Kimberly
- Torguson, Rebecca
- Waksman, Ron
Year: 2014
Citation: - Jacc: Cardiovascular Interventions. 7(10):1093-102, 2014 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Applegate R, Cohen DJ, DESERT Investigators, Gordon P, Kaneshige K, Kirtane AJ, Leon MB, Raber L, Ryan T, Torguson R, Waksman R, Waxman S
|
|
|
21.
|
Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving beta-blockers. MedStar authors:
- Bhyan, Poonam
- Dooley, Daniel J
- Lam, Phillip H
- Mohammed, Selma F
Year: 2018
Citation: - Clinical Cardiology. 41(3):406-412, 2018 Mar.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Ahmed A, Allman RM, Aronow WS, Arundel C, Bhyan P, Dooley DJ, Fonarow GC, Lam PH, Mohammed SF, Morgan CJ, Sheriff HM, Waagstein F
|
|
|
22.
|
Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting beta-Agonist for Step-Up Therapy in Asthma. MedStar authors:
Year: 2015
Citation: - Annals of the American Thoracic Society. 12(6):798-806, 2015 Jun.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Burden A, Colice G, Dorinsky PM, Grigg J, Guilbert TW, Hillyer EV, Israel E, Martin RJ, Postma DS, Price DB, Roche N, Thomas V, van Aalderen WM, von Ziegenweidt J
|
|
|
23.
|
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial. MedStar authors:
- Bastian, Roshni
- Chandra, Nina
- Garcia-Garcia, Hector M
- Leiboff, Roy
- Spad, Mia-Ashley
- Torguson, Rebecca
- Waksman, Ron
- Wang, John
Year: 2017
Citation: - Cardiovascular Revascularization Medicine. 18(7):475-481, 2017 Oct - Nov.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Southern Maryland Hospital Center
- MedStar Union Memorial Hospital
Medline publication type:
All authors: - Adams G, Bastian R, Cannon L, Chandra N, DeGroot J, Garcia-Garcia HM, Kabour A, Kayo MW, Kereiakes DJ, Leiboff R, Piegari GN, Smeglin A, Solankhi N, Spad MA, Stoll HP, Torguson R, Waksman R, Wang J
|
|
|
24.
|
|
|
|
25.
|
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. MedStar authors:
Year: 2021
Citation: - Hepatology. 74(6):2952-2964, 2021 12.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Darling JM, Di Bisceglie A, Dong M, Evon DM, Fishbein DA, Fried MW, Hinestrosa F, Horne PM, Khalili M, Kixmiller S, Lok AS, Michael L, Moon JS, Morelli G, Muir AJ, Nelson DR, Pearlman B, Peter J, PRIORITIZE Study Team, Rajender Reddy K, Segal JB, Sherman KE, Shiffman ML, Sloan A, Stewart PW, Sulkowski MS, Vainorius M, Wadsworth S
|
|
|
26.
|
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
Year: 2020
Citation: - Diabetes Care. 43(5):940-947, 2020 05.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
|
|
|
27.
|
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. MedStar authors:
Citation: - Gut. 63(1):161-9, 2014 Jan.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Gastroenterology
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
All authors: - Abdalla A, Ahlenstiel G, Dahari H, Doo E, Edlich B, Feld JJ, Gara N, Ghany MG, Guedj J, Han H, Heller T, Hogdal L, Hoofnagle JH, Koh C, Liang TJ, Noureddin M, Park SH, Park YJ, Perelson AS, Rehermann B, Rotman Y, Sarkar S, Thomas E, Titerence R, Witthaus M
|
|
|
28.
|
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(11):2108-2116, 2019 11.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
|
|
|
29.
|
Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis. [Review] MedStar authors:
- Gaglia, Michael AJ
- Garcia-Garcia, Hector M
- Lee, Regina C
- Lipinski, Michael J
- Pichard, Augusto D
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
Year: 2016
Citation: - Cardiovascular Revascularization Medicine. 17(8):535-545, 2016 Dec
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Meta-Analysis
- Review
All authors: - Gaglia MA Jr, Garcia-Garcia HM, Lee RC, Lipinski MJ, Pichard AD, Satler LF, Torguson R, Waksman R
|
